SINGAPORE, June 19, 2024 – Marketing In Asia is excited to announce that Mobile-health Network Solutions, known as MaNaDr (Nasdaq: MNDR), a pioneering telehealth provider in the Asia-Pacific (APAC) region, has unveiled updated pricing for its medical weight management program. This initiative aims to make GLP-1 (glucagon-like peptide-1) receptor agonist medications more affordable and accessible across APAC.
The program, aimed at curbing the increasing obesity rates in Singapore and the wider APAC region, is positioned as one of the most competitively priced options available. MaNaDr anticipates a significant uptake of the program, driving substantial incremental revenue from the third quarter of the current year.
Ms. Law Pei Bei, Chief Business Officer, remarked, “Leveraging our strong partnerships, we offer a range of GLP-1 medications directly sourced from the leading pharmaceutical innovators. This means patients have access to the original, brand-name GLP-1 injections, ensuring the highest quality and proven results. We’ve negotiated competitive pricing with these leading pharmaceutical manufacturers, allowing us to offer original GLP-1 medications at pricing starting at less than US$10 per day. This low pricing makes these treatments a realistic option for most weight management patients.”
Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician and Co-CEO, added, “Telehealth consultations create a safe and comfortable environment for weight management discussions. This is especially beneficial for individuals who may experience shyness, social anxiety, or fear in a traditional setting. Telehealth empowers these patients to openly discuss their weight loss goals and challenges, fostering a supportive foundation for their journey.”
Also Read: WhatsApp Rolls Out Default HD Quality Setting for Media Sharing
Branded with the tagline, “It’s Okay to be Not Okay,” MaNaDr’s program is unique in the APAC region, providing a one-stop solution for all weight management needs. The program encompasses:
Medical Intervention: Patients can consult with doctors for personalized medical advice, including the suitability of GLP-1 medications such as Semaglutide (Wegovy, Rybelsus), Liraglutide (Saxenda), Dulaglutide (Trucility), or other prescription weight loss medications.
Mental/Emotional Support: Ongoing support from a dedicated personal care consultant and coach to help set achievable goals, navigate challenges, and celebrate successes.
Nutritional Guidance: Registered dietitians work with patients to develop personalized, sustainable eating plans.
Fitness Expertise: Certified exercise instructors help create tailored exercise programs.
24/7 Availability: Patients have round-the-clock access to their healthcare team for immediate concerns.
Data-Driven Tracking: A user-friendly personal lifestyle diary helps monitor meals, physical activity, and body measurements.
Community Forum: An in-app forum offers peer support with anonymity for those hesitant to share in traditional group settings.
Effortless Refills: Quick and easy prescription refills within the MaNaDr app.
In-Clinic Option: For those preferring in-person visits, comprehensive physical evaluations can be scheduled.
Dr. Rachel Teoh Pui Pui, PBM, Family Physician and Co-CEO, emphasized, “Many weight management solutions available today ultimately fail – partly because patients do not receive the help they need, when they need it. Our program addresses these challenges by prioritizing the three elements we believe are essential to successful weight loss: effective prescription medications, 24/7 mental health support, and personalized nutritional and fitness guidance. Several recent studies demonstrate that GLP-1 medications like Saxenda can help most patients lose five to ten percent of their body weight within a reasonable period of time. Should patients experience side effects from using such medications, we will consider offering other medications, both prescription and over-the-counter, that will best help patients achieve a safe and successful outcome of their weight management goals.”
She added, “Equally important is the availability of professional mental health support for weight management patients. Often underestimated, and even overlooked, is the fear, isolation, cravings, and shame experienced by many patients with weight management issues. We address these needs by making certain that patients have a dedicated personal care consultant and coach who is thoroughly familiar with a patient’s needs, and by making a professional available to consult with patients on a 24/7 basis. No patient in our program will ever have their needs ignored when they need help.”
Dr. Siaw concluded, “We’re excited to launch this comprehensive weight management program. By combining access to medical professionals, highly effective weight loss medications, nutritional guidance, and fitness expertise, all within one app, we’re empowering individuals to achieve their goals holistically and sustainably.”
About Mobile-health Network Solutions Pte Ltd [MaNaDr]
Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, ManNaDr is the first telehealth provider from the Asia-Pacific region to be listed in the US (Nasdaq). Through its MaNaDr platform app, it offers personalized and reliable medical attention to users worldwide. The platform allows the community of healthcare providers to have a broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. The range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit https://manadr.com. For Investor Relations, please visit https://investors.manadr.com.
Considering GLP-1 medications for weight management? Learn more about this option and explore if it’s right for you. Visit our website https://manadr.com/weight-management or schedule a convenient teleconsultation with our specialist doctors through the MaNaDr app.
Legal Disclaimer: The Editor provides this news content "as is," without any warranty of any kind. We disclaim all responsibility and liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. For any complaints or copyright concerns regarding this article, please contact the author mentioned above.
